| 1 | Gynecomastia | 31.8% |
| 2 | Follicular cyst | 27.9% |
| 3 | Mucocele | 27.9% |
| 4 | Pilonidal Cyst | 27.9% |
| 5 | Thyroglossal Cyst | 27.9% |
| 6 | Synovial Cyst | 27.9% |
| 7 | Dermoid Cyst | 24.8% |
| 8 | Pyoderma Gangrenosum | 24.3% |
| 9 | Myxoid cyst | 24.1% |
| 10 | Lactation Disorder | 23.7% |
| 11 | Mastitis | 23.7% |
| 12 | Skin Neoplasms | 22.8% |
| 13 | Breast Neoplasms, Male | 22.7% |
| 14 | Triple Negative Breast Neoplasms | 22.7% |
| 15 | Lupus Erythematosus, Cutaneous | 21.1% |
| 16 | Lymphocele | 21.1% |
| 17 | Pancreatic Cyst | 21.1% |
| 18 | Panniculitis | 21.1% |
| 19 | Systemic Scleroderma | 21.1% |
| 20 | Morphea | 21.1% |
| 21 | Dermatitis | 20.9% |
| 22 | Exanthema | 20.9% |
| 23 | Facial Dermatoses | 20.9% |
| 24 | Hair Diseases | 20.9% |
| 25 | Hand Dermatoses | 20.9% |
| 26 | keratoacanthoma | 20.9% |
| 27 | Keratosis | 20.9% |
| 28 | Nail Diseases | 20.9% |
| 29 | Photosensitivity Disorders | 20.9% |
| 30 | Prurigo | 20.9% |
| 31 | Pyoderma | 20.9% |
| 32 | Rosacea | 20.9% |
| 33 | Sebaceous Gland Diseases | 20.9% |
| 34 | Skin Diseases, Vesiculobullous | 20.9% |
| 35 | Skin Ulcer | 20.9% |
| 36 | Sweat Gland Diseases | 20.9% |
| 37 | Skin Diseases, Papulosquamous | 20.9% |
| 38 | Skin Diseases, Vascular | 20.9% |
| 39 | Acneiform Eruptions | 20.9% |
| 40 | Ocular Rosacea | 20.9% |
| 41 | Subcorneal pustular dermatosis | 20.9% |
| 42 | Erythematotelangiectatic Rosacea | 20.9% |
| 43 | Papulopustular Rosacea | 20.9% |
| 44 | Chronic Actinic Dermatitis | 20.9% |
| 45 | Mediastinal Cyst | 20.7% |
| 46 | Parovarian Cyst | 20.7% |
| 47 | Pericardial Cyst | 20.7% |
| 48 | Thymic Cyst | 20.7% |
| 49 | Acne Vulgaris | 20.3% |
| 50 | Contact Dermatitis | 20.3% |
| 51 | Eczema | 20.3% |
| 52 | Erythema Multiforme | 20.3% |
| 53 | Intertrigo | 20.3% |
| 54 | Neurodermatitis | 20.3% |
| 55 | Rhinophyma | 20.3% |
| 56 | Perioral Dermatitis | 20.3% |
| 57 | Acne | 20.3% |
| 58 | Sebaceous Gland Neoplasms | 20.3% |
| 59 | Carcinoma, Lobular | 20.1% |
| 60 | Xeroderma Pigmentosum | 18.9% |
| 61 | Dermatitis, Phototoxic | 17.9% |
| 62 | Pityriasis Lichenoides et Varioliformis Acuta | 17.9% |
| 63 | Pityriasis Lichenoides | 17.9% |
| 64 | Phototoxicity | 17.9% |
| 65 | Foot Ulcer | 17.6% |
| 66 | Galactorrhea | 17.5% |
| 67 | Dermatitis, Atopic | 17.3% |
| 68 | Epidermolysis Bullosa | 17.3% |
| 69 | Actinic keratosis | 17.2% |
| 70 | Urticaria Pigmentosa | 16.7% |
| 71 | Dermatitis Herpetiformis | 16.4% |
| 72 | Foot Diseases | 16.4% |
| 73 | Corpus Luteum Cyst | 16.3% |
| 74 | Ovarian Cysts | 16.3% |
| 75 | Acrodermatitis | 16.2% |
| 76 | Porokeratosis | 16.2% |
| 77 | Gianotti-Crosti Syndrome | 16.2% |
| 78 | Keratoderma, Palmoplantar | 16.2% |
| 79 | Skin Abnormalities | 15.8% |
| 80 | Skin Diseases, Infectious | 15.8% |
| 81 | Pigmentation Disorders | 15.8% |
| 82 | Mastocytosis | 15.6% |
| 83 | Panniculitis, Lupus Erythematosus | 15.6% |
| 84 | Lipomatosis | 15.5% |
| 85 | Pruritus | 15.5% |
| 86 | Erythema | 15.5% |
| 87 | Necrolytic Migratory Erythema | 15.5% |
| 88 | Cutaneous Fistula | 15.5% |
| 89 | Nephrogenic Fibrosing Dermopathy | 15.5% |
| 90 | Nephrogenic Systemic Fibrosis | 15.5% |
| 91 | Pancreatic Pseudocyst | 15.3% |
| 92 | Necrobiosis Lipoidica Diabeticorum | 15.1% |
| 93 | Dermatitis, Irritant | 15% |
| 94 | Acne Conglobata | 15% |
| 95 | Dermatitis, Photoallergic | 14.8% |
| 96 | Hamartoma | 14.6% |
| 97 | Neoplasms, Hormone-Dependent | 14.6% |
| 98 | Neoplasms, Multiple Primary | 14.6% |
| 99 | Paraneoplastic Syndromes | 14.6% |
| 100 | Precancerous Conditions | 14.6% |
| 101 | Neoplasms, Second Primary | 14.6% |
| 102 | Mastocytoma | 13.8% |
| 103 | Choledochal Cyst | 13.8% |
| 104 | Anhidrosis | 13.6% |
| 105 | Cholesteatoma | 13.6% |
| 106 | Pressure Ulcer | 13.6% |
| 107 | Folliculitis | 13.6% |
| 108 | Foot Dermatoses | 13.6% |
| 109 | Hypertrichosis | 13.6% |
| 110 | Hypohidrosis | 13.6% |
| 111 | Hypotrichosis | 13.6% |
| 112 | Leg Ulcer | 13.6% |
| 113 | Miliaria | 13.6% |
| 114 | Parakeratosis | 13.6% |
| 115 | Parapsoriasis | 13.6% |
| 116 | Pityriasis | 13.6% |
| 117 | Psoriasis | 13.6% |
| 118 | Xeroderma | 13.6% |
| 119 | Sweet Syndrome | 13.6% |
| 120 | Hidradenitis | 13.6% |
| 121 | Onycholysis | 13.6% |
| 122 | Miliaria Rubra | 13.6% |
| 123 | Hyperpigmentation | 13.6% |
| 124 | Lichenoid Eruptions | 13.6% |
| 125 | Chloracne | 13.6% |
| 126 | Dermatomyositis | 13.6% |
| 127 | Lupus Erythematosus, Discoid | 13.6% |
| 128 | Scleroderma, Limited | 13.6% |
| 129 | Erythema Induratum | 13% |
| 130 | Dermatitis, Occupational | 12.5% |
| 131 | Diaper Rash | 12.4% |
| 132 | Cutis Laxa | 12.3% |
| 133 | Connective Tissue Diseases | 12.2% |
| 134 | Dermatitis, Allergic Contact | 12% |
| 135 | Polycystic Ovary Syndrome | 11.9% |
| 136 | Papillon-Lefevre Disease | 11.9% |
| 137 | Erythema Infectiosum | 11.9% |
| 138 | Exanthema Subitum | 11.8% |
| 139 | Carcinoma 256, Walker | 11.8% |
| 140 | Erythema Nodosum | 11.6% |
| 141 | Ectodermal Dysplasia | 11.5% |
| 142 | Aplasia Cutis Congenita | 11.5% |
| 143 | Pseudoxanthoma Elasticum | 11.2% |
| 144 | Carcinoma, Ehrlich Tumor | 11.1% |
| 145 | Toxic Epidermal Necrolysis | 11.1% |
| 146 | Stevens-Johnson Syndrome | 11.1% |
| 147 | Carcinoma, Lewis Lung | 11.1% |
| 148 | Neoplastic Processes | 10.9% |
| 149 | Neoplastic Syndromes, Hereditary | 10.9% |
| 150 | Pregnancy Complications, Neoplastic | 10.9% |
| 151 | Multiple Endocrine Neoplasia | 10.9% |
| 152 | Neoplasms, Experimental | 10.7% |
| 153 | Tinea Capitis | 10.7% |
| 154 | Onychomycosis | 10.7% |
| 155 | Neoplasms, Neuroepithelial | 10.7% |
| 156 | Gliomatosis cerebri | 10.7% |
| 157 | Medulloblastoma | 10.5% |
| 158 | Acantholysis | 10.3% |
| 159 | Pemphigoid, Benign Mucous Membrane | 10.3% |
| 160 | Pemphigus | 10.3% |
| 161 | Piedra | 10.3% |
| 162 | Sunburn | 10.3% |
| 163 | Argyria | 10.2% |
| 164 | Hirsutism | 10.2% |
| 165 | Urticaria | 10.2% |
| 166 | Neuroectodermal Tumors | 10.2% |
| 167 | Melanoma, Experimental | 10.2% |
| 168 | Lichen Planus | 10.1% |
| 169 | Melanosis | 10.1% |
| 170 | Chloasma | 10.1% |
| 171 | Pityriasis Rosea | 10.1% |
| 172 | Pityriasis Rubra Pilaris | 10.1% |
| 173 | Vitiligo | 10.1% |
| 174 | Lichen Nitidus | 10.1% |
| 175 | Adiposis Dolorosa | 10.1% |
| 176 | Pruritus Vulvae | 10.1% |
| 177 | Granuloma Annulare | 10.1% |
| 178 | Pruritus Ani | 10% |
| 179 | Ecthyma | 10% |
| 180 | melanoma | 9.9% |
| 181 | Hyperkeratosis, Epidermolytic | 9.8% |
| 182 | Paraneoplastic Encephalomyelitis | 9.7% |
| 183 | Trophoblastic Neoplasms | 9.6% |
| 184 | Leukemia, Experimental | 9.5% |
| 185 | Mammary Neoplasms, Experimental | 9.5% |
| 186 | Abdominal Neoplasms | 9.3% |
| 187 | Erythroplasia | 9.3% |
| 188 | Head and Neck Neoplasms | 9.3% |
| 189 | leukemia | 9.3% |
| 190 | Neoplasms, Germ Cell and Embryonal | 9.3% |
| 191 | Neoplasms, Glandular and Epithelial | 9.3% |
| 192 | Soft Tissue Neoplasms | 9.3% |
| 193 | Thoracic Neoplasms | 9.3% |
| 194 | Germ Cell Cancer | 9.3% |
| 195 | Aberrant Crypt Foci | 9.3% |
| 196 | Carcinosarcoma | 9.2% |
| 197 | Hemangiosarcoma | 9.2% |
| 198 | Leukemia L1210 | 9.2% |
| 199 | Leukemia P388 | 9.2% |
| 200 | lymphangiosarcoma | 9.2% |
| 201 | Acanthoma | 9.2% |
| 202 | Adenoma, Acidophil | 9.2% |
| 203 | Ganglioneuroma | 9.2% |
| 204 | Glioma | 9.2% |
| 205 | Malignant Glioma | 9.2% |
| 206 | Basal Cell Nevus Syndrome | 9.2% |
| 207 | Meningioma | 9.1% |
| 208 | Ichthyosis, X-Linked | 9% |
| 209 | Sjogren-Larsson Syndrome | 9% |
| 210 | Carcinoid Tumor | 8.9% |
| 211 | Neurilemmoma | 8.9% |
| 212 | Hutchinson's Melanotic Freckle | 8.9% |
| 213 | Melanoma, Amelanotic | 8.9% |
| 214 | Behcet Syndrome | 8.8% |
| 215 | Sarcoma 180 | 8.8% |
| 216 | Sarcoma, Experimental | 8.8% |
| 217 | Choriocarcinoma | 8.5% |
| 218 | Hidradenitis Suppurativa | 8.5% |
| 219 | Neoplasms, Radiation-Induced | 8.5% |
| 220 | Astrocytoma | 8.5% |
| 221 | Ependymoma | 8.5% |
| 222 | oligodendroglioma | 8.5% |
| 223 | Ganglioglioma | 8.5% |
| 224 | gliosarcoma | 8.5% |
| 225 | Anaplastic astrocytoma | 8.5% |
| 226 | Anaplastic Oligodendroglioma | 8.5% |
| 227 | Acanthosis Nigricans | 8.4% |
| 228 | Alopecia Areata | 8.4% |
| 229 | Lentigo | 8.4% |
| 230 | Basal cell carcinoma | 8.3% |
| 231 | Carcinoma, Papillary | 8.3% |
| 232 | Squamous cell carcinoma | 8.3% |
| 233 | Chondrosarcoma | 8.3% |
| 234 | Craniopharyngioma | 8.3% |
| 235 | Cystadenoma | 8.3% |
| 236 | leiomyosarcoma | 8.3% |
| 237 | liposarcoma | 8.3% |
| 238 | Mesothelioma | 8.3% |
| 239 | synovial sarcoma | 8.3% |
| 240 | Neuroectodermal Tumor, Melanotic | 8.3% |
| 241 | Angiomyolipoma | 8.3% |
| 242 | Clear Cell Sarcoma of Soft Tissue | 8.3% |
| 243 | Alveolar Soft Part Sarcoma | 8.3% |
| 244 | Neuroendocrine Tumors | 8.3% |
| 245 | Sarcoma, Myeloid | 8.3% |
| 246 | Carcinoma, Basal Cell | 8.3% |
| 247 | Malignant Carcinoid Syndrome | 8.3% |
| 248 | Peutz-Jeghers Syndrome | 8.3% |
| 249 | Dermatomycoses | 8.2% |
| 250 | Mucocutaneous Lymph Node Syndrome | 8.2% |
| 251 | Skin Diseases, Bacterial | 8.2% |
| 252 | Glioblastoma | 8.1% |
| 253 | Neuroblastoma | 8.1% |
| 254 | Glioblastoma Multiforme | 8.1% |
| 255 | Drug Eruptions | 8.1% |
| 256 | Lipodystrophy | 8.1% |
| 257 | Livedo Reticularis | 8.1% |
| 258 | Malignant Atrophic Papulosis | 8.1% |
| 259 | Multiple Endocrine Neoplasia Type 1 | 8.1% |
| 260 | Leukemia, Radiation-Induced | 8% |
| 261 | Polyarteritis Nodosa | 8% |
| 262 | Takayasu Arteritis | 8% |
| 263 | Ganglioneuroblastoma | 8% |
| 264 | Cystadenocarcinoma | 7.9% |
| 265 | Fibrosarcoma | 7.9% |
| 266 | Osteosarcoma | 7.9% |
| 267 | Mucoepidermoid Carcinoma | 7.9% |
| 268 | Albinism | 7.8% |
| 269 | Tinea Pedis | 7.7% |
| 270 | Alopecia | 7.7% |
| 271 | Sweating, Gustatory | 7.7% |
| 272 | Androgenetic Alopecia | 7.7% |
| 273 | Auriculotemporal Syndrome | 7.7% |
| 274 | Adenofibroma | 7.7% |
| 275 | Fibroadenoma | 7.7% |
| 276 | Malignant Fibrous Histiocytoma | 7.7% |
| 277 | Erythema Chronicum Migrans | 7.7% |
| 278 | Lice Infestations | 7.6% |
| 279 | Varicose Ulcer | 7.6% |
| 280 | Tuberous Sclerosis | 7.4% |
| 281 | Bowen's Disease | 7.4% |
| 282 | Paraganglioma | 7.4% |
| 283 | Rhabdomyosarcoma | 7.4% |
| 284 | Giant Cell Tumor of Bone | 7.4% |
| 285 | Thymoma | 7.4% |
| 286 | Leukemia, Plasma Cell | 7.3% |
| 287 | Digestive System Neoplasms | 7.3% |
| 288 | Endocrine Gland Neoplasms | 7.3% |
| 289 | Eye Neoplasms | 7.3% |
| 290 | Nervous System Neoplasms | 7.3% |
| 291 | Dermatofibrosarcoma | 7.2% |
| 292 | Dermatofibrosarcoma Protuberans | 7.2% |
| 293 | Bone neoplasms | 7% |
| 294 | Leukoplakia | 7% |
| 295 | Hematologic Neoplasms | 7% |
| 296 | Retinoblastoma | 7% |
| 297 | Pheochromocytoma | 7% |
| 298 | Alveolar rhabdomyosarcoma | 7% |
| 299 | Collagen Diseases | 7% |
| 300 | Mixed Connective Tissue Disease | 7% |
| 301 | Mucinoses | 7% |
| 302 | Dupuytren Contracture | 6.9% |
| 303 | Lymphomatoid Granulomatosis | 6.9% |
| 304 | Barrett Esophagus | 6.9% |
| 305 | Histiocytic Disorders, Malignant | 6.9% |
| 306 | Nail-Patella Syndrome | 6.9% |
| 307 | Neoplasm Invasiveness | 6.9% |
| 308 | Neoplasm Metastasis | 6.9% |
| 309 | Neoplasm Recurrence, Local | 6.9% |
| 310 | Parathyroid Neoplasms | 6.9% |
| 311 | Peritoneal Neoplasms | 6.9% |
| 312 | Splenic Neoplasms | 6.9% |
| 313 | Thyroid Neoplasm | 6.9% |
| 314 | Thyroid carcinoma | 6.9% |
| 315 | Carcinogenesis | 6.9% |
| 316 | Metastasis | 6.9% |
| 317 | Carcinoma, Pancreatic Ductal | 6.9% |
| 318 | Adenoma | 6.8% |
| 319 | Ameloblastoma | 6.8% |
| 320 | Angiokeratoma | 6.8% |
| 321 | Carcinoma | 6.8% |
| 322 | Chordoma | 6.8% |
| 323 | Hemangioma | 6.8% |
| 324 | hemangiopericytoma | 6.8% |
| 325 | Lymphangioma | 6.8% |
| 326 | Mesenchymoma | 6.8% |
| 327 | Nevus | 6.8% |
| 328 | Retroperitoneal Neoplasms | 6.8% |
| 329 | Teratoma | 6.8% |
| 330 | Porphyrias, Hepatic | 6.8% |
| 331 | Hepatoblastoma | 6.8% |
| 332 | Mixed Tumor, Mullerian | 6.8% |
| 333 | Germinoma | 6.8% |
| 334 | Teratocarcinoma | 6.8% |
| 335 | Angiofibroma | 6.8% |
| 336 | Sarcoma | 6.8% |
| 337 | Epithelioma | 6.8% |
| 338 | Carcinoid Heart Disease | 6.8% |
| 339 | Composite Lymphoma | 6.7% |
| 340 | Acoustic Neuroma | 6.6% |
| 341 | Mycetoma | 6.6% |
| 342 | Lichen Planus, Oral | 6.4% |
| 343 | Vipoma | 6.3% |
| 344 | Tracheal Neoplasms | 6.3% |
| 345 | Hydatidiform Mole | 6.2% |
| 346 | Liver Neoplasms, Experimental | 6.2% |
| 347 | Leukoplakia, Oral | 6.1% |
| 348 | Neurofibrosarcoma | 6.1% |
| 349 | Larva Migrans | 6.1% |
| 350 | Leishmaniasis | 6.1% |
| 351 | Molluscum Contagiosum | 6.1% |
| 352 | Nephroblastoma | 6.1% |
| 353 | Paraneoplastic Cerebellar Degeneration | 6.1% |
| 354 | Angioedema | 6.1% |
| 355 | Onchocerciasis | 6.1% |
| 356 | Chromoblastomycosis | 6% |
| 357 | Dermatophytosis | 6% |
| 358 | Sporotrichosis | 6% |
| 359 | Tinea | 6% |
| 360 | Tinea Versicolor | 6% |
| 361 | Trichophytosis | 6% |
| 362 | Hyalohyphomycosis | 6% |
| 363 | Radicular Cyst | 6% |
| 364 | Acute Generalized Exanthematous Pustulosis | 6% |
| 365 | Pancreatic Neoplasm | 5.9% |
| 366 | Optic Nerve Glioma | 5.9% |
| 367 | Endometrial Stromal Sarcoma | 5.7% |
| 368 | Adenocarcinoma | 5.6% |
| 369 | Carcinoma in Situ | 5.6% |
| 370 | Carcinoma, Transitional Cell | 5.6% |
| 371 | Phyllodes Tumor | 5.6% |
| 372 | Dysgerminoma | 5.6% |
| 373 | Hemangioendothelioma | 5.6% |
| 374 | Lipoma | 5.6% |
| 375 | Myoma | 5.6% |
| 376 | Myxoma | 5.6% |
| 377 | Neuroma | 5.6% |
| 378 | Papilloma | 5.6% |
| 379 | Pseudomyxoma Peritonei | 5.6% |
| 380 | Seminoma | 5.6% |
| 381 | Papillomatosis | 5.6% |
| 382 | Angiolipoma | 5.6% |
| 383 | Myelolipoma | 5.6% |
| 384 | Neoplasms, Bone Tissue | 5.6% |
| 385 | Neoplasms, Fibrous Tissue | 5.6% |
| 386 | Smooth Muscle Tumor | 5.6% |
| 387 | Adenomatosis, Pulmonary | 5.6% |
| 388 | Adenomatous Polyps | 5.6% |
| 389 | Carcinoma, Large Cell | 5.6% |
| 390 | Carcinoma, Small Cell | 5.6% |
| 391 | Desmoplastic Small Round Cell Tumor | 5.6% |
| 392 | Chondroma | 5.6% |
| 393 | Enchondroma | 5.6% |
| 394 | Thyroid Nodule | 5.6% |
| 395 | Hepatocellular Adenoma | 5.6% |
| 396 | insulinoma | 5.5% |
| 397 | Lymphangioleiomyomatosis | 5.5% |
| 398 | Lymphoma | 5.5% |
| 399 | Cartilage Diseases | 5.5% |
| 400 | Rheumatism | 5.5% |
| 401 | Chondromalacia | 5.5% |
| 402 | Gastrinoma | 5.4% |
| 403 | Glucagonoma | 5.4% |
| 404 | Esophageal Neoplasms | 5.3% |
| 405 | Lupus Erythematosus, Systemic | 5.3% |
| 406 | Overlap syndrome | 5.3% |
| 407 | Limbic Encephalitis | 5.2% |
| 408 | Mouth Neoplasms | 5.2% |
| 409 | Central Nervous System Neoplasms | 5.2% |
| 410 | Vascular Neoplasms | 5.2% |
| 411 | Thymus Neoplasms | 5.2% |
| 412 | Warts | 5.1% |
| 413 | Genital Neoplasms, Female | 5.1% |
| 414 | Plasmacytoma | 5.1% |
| 415 | Malignant histiocytosis | 5% |
| 416 | Lymphatic Metastasis | 5% |
| 417 | Neoplasms, Unknown Primary | 5% |
| 418 | Leukemic Infiltration | 5% |
| 419 | Histiocytic sarcoma | 5% |
| 420 | Neoplasm Micrometastasis | 5% |
| 421 | Adenoid Cystic Carcinoma | 5% |
| 422 | fibroma | 5% |
| 423 | Fibromatosis | 5% |
| 424 | Osteoblastoma | 5% |
| 425 | Osteoma | 5% |
| 426 | Rhabdomyoma | 5% |
| 427 | Chondromatosis | 5% |
| 428 | Adenocarcinoma, Clear Cell | 5% |
| 429 | Cholangiocarcinoma | 5% |
| 430 | Cervical Intraepithelial Neoplasia | 5% |
| 431 | Hemangioblastoma | 5% |
| 432 | Lymphoma, Extranodal NK-T-Cell | 5% |
| 433 | Candidiasis, Chronic Mucocutaneous | 5% |
| 434 | Cutaneous Candidiasis | 5% |
| 435 | Leishmaniasis, Cutaneous | 5% |
| 436 | Eczema Herpeticum | 5% |
| 437 | Adenomatous Polyposis Coli | 5% |
| 438 | Erysipelas | 5% |
| 439 | Serum Sickness | 5% |
| 440 | Staphylococcal Skin Infections | 5% |
| 441 | Variegate Porphyria | 5% |
| 442 | Acute intermittent porphyria | 5% |
| 443 | Porphyria Cutanea Tarda | 5% |
| 444 | Erythrasma | 5% |
| 445 | Arthritis, Psoriatic | 4.9% |
| 446 | Fusariosis | 4.9% |
| 447 | CREST Syndrome | 4.9% |
| 448 | Leydig Cell Tumor | 4.8% |
| 449 | Fibromatosis, Aggressive | 4.7% |
| 450 | Fibromatosis, Abdominal | 4.7% |
| 451 | Klatskin Tumor | 4.7% |
| 452 | Prolactinoma | 4.7% |
| 453 | Growth Hormone-Secreting Pituitary Adenoma | 4.7% |
| 454 | Lambert-Eaton Myasthenic Syndrome | 4.6% |
| 455 | Testicular Neoplasms | 4.6% |
| 456 | Scleromyxedema | 4.5% |
| 457 | Hereditary Angioedema Type III | 4.4% |
| 458 | Hereditary Angioedema Types I and II | 4.4% |
| 459 | Giant Cell Arteritis | 4.4% |
| 460 | Temporal Arteritis | 4.4% |
| 461 | Mesoblastic Nephroma | 4.3% |
| 462 | Adrenocortical carcinoma | 4.2% |
| 463 | Meningeal Neoplasms | 4.2% |
| 464 | Angioedemas, Hereditary | 4.2% |
| 465 | Adrenal Gland Neoplasms | 4.2% |
| 466 | Gastrointestinal Neoplasms | 4.2% |
| 467 | Genital Neoplasms, Male | 4.2% |
| 468 | Leukemia, Myelomonocytic, Chronic | 4.2% |
| 469 | Liver neoplasms | 4.2% |
| 470 | Uveal Neoplasms | 4.2% |
| 471 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 4.2% |
| 472 | Epidermodysplasia Verruciformis | 4.2% |
| 473 | Herpes Labialis | 4.2% |
| 474 | Diabetic Foot | 4.1% |
| 475 | Urologic Neoplasms | 4.1% |
| 476 | Opsoclonus-Myoclonus Syndrome | 4.1% |
| 477 | granulosa cell tumor | 4.1% |
| 478 | Carcinoma, Ovarian Epithelial | 4.1% |
| 479 | Staphylococcal Scalded Skin Syndrome | 4.1% |
| 480 | Spinal Neoplasms | 4.1% |
| 481 | Bone Marrow Neoplasms | 4.1% |
| 482 | Hodgkin Disease | 4% |
| 483 | Lymphoma, Non-Hodgkin | 4% |
| 484 | Palatal Neoplasms | 3.9% |
| 485 | Nose Neoplasms | 3.8% |
| 486 | Blastomycosis | 3.7% |
| 487 | Meningeal Carcinomatosis | 3.7% |
| 488 | Mastocytosis, Systemic | 3.7% |
| 489 | Leukemia, Myeloid, Chronic-Phase | 3.7% |
| 490 | HIV-Associated Lipodystrophy Syndrome | 3.7% |
| 491 | Renal Cell Carcinoma | 3.7% |
| 492 | Papillary Renal Cell Carcinoma | 3.7% |
| 493 | carbuncle | 3.7% |
| 494 | Myelitis, Transverse | 3.6% |
| 495 | Condylomata Acuminata | 3.6% |
| 496 | Furunculosis | 3.5% |
| 497 | furuncle | 3.5% |
| 498 | Carcinoma, Endometrioid | 3.5% |
| 499 | Denys-Drash Syndrome | 3.5% |
| 500 | Impetigo | 3.5% |
| 501 | Ear Neoplasms | 3.4% |
| 502 | Eyelid Neoplasms | 3.4% |
| 503 | Lung Neoplasms | 3.4% |
| 504 | Mesenteric Panniculitis | 3.4% |
| 505 | Panniculitis, Peritoneal | 3.4% |
| 506 | Pleural Neoplasms | 3.4% |
| 507 | Tietze's Syndrome | 3.4% |
| 508 | Orbital Cellulitis | 3.4% |
| 509 | Sturge-Weber Syndrome | 3.4% |
| 510 | Cellulitis | 3.4% |
| 511 | Myxedema | 3.4% |
| 512 | Rhinoscleroma | 3.4% |
| 513 | Cell Transformation, Viral | 3.4% |
| 514 | Brain Neoplasms | 3.4% |
| 515 | Salivary Gland Neoplasms | 3.4% |
| 516 | Spinal Cord Neoplasms | 3.4% |
| 517 | Tongue Neoplasms | 3.4% |
| 518 | Gastrointestinal Stromal Tumors | 3.4% |
| 519 | Nasopharyngeal carcinoma | 3.4% |
| 520 | Primary amyloidosis | 3.4% |
| 521 | Pituitary Adenoma | 3.3% |
| 522 | Pituitary Neoplasms | 3.3% |
| 523 | Hemangioma, Cavernous | 3.3% |
| 524 | Leukemia, T-Cell | 3.3% |
| 525 | Uterine Neoplasms | 3.3% |
| 526 | Vaginal Neoplasms | 3.3% |
| 527 | Vulvar Neoplasms | 3.3% |
| 528 | Uterine Cancer | 3.3% |
| 529 | Leukemia, B-Cell | 3.3% |
| 530 | Fallopian Tube Neoplasms | 3.3% |
| 531 | neurofibroma | 3.3% |
| 532 | Lymphoma, Follicular | 3.3% |
| 533 | T-Cell Lymphoma | 3.3% |
| 534 | Mantle cell lymphoma | 3.3% |
| 535 | Menkes Kinky Hair Syndrome | 3.3% |
| 536 | Bronchial Neoplasms | 3.1% |
| 537 | Multiple Pulmonary Nodules | 3% |
| 538 | Supratentorial Neoplasms | 3% |
| 539 | Endometrial Neoplasms | 3% |
| 540 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3% |
| 541 | Leukemia, Large Granular Lymphocytic | 3% |
| 542 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3% |
| 543 | Lymphoma, T-Cell, Cutaneous | 2.9% |
| 544 | Lymphoma, AIDS-Related | 2.9% |
| 545 | Enteropathy-Associated T-Cell Lymphoma | 2.9% |
| 546 | Primary Effusion Lymphoma | 2.9% |
| 547 | Pharyngeal Neoplasms | 2.9% |
| 548 | ovarian neoplasm | 2.9% |
| 549 | Central Nervous System Cysts | 2.8% |
| 550 | Bile Duct Neoplasms | 2.8% |
| 551 | gallbladder neoplasm | 2.8% |
| 552 | Intestinal Neoplasms | 2.8% |
| 553 | Penile Neoplasms | 2.8% |
| 554 | Prostatic Neoplasms | 2.8% |
| 555 | Stomach Neoplasms | 2.8% |
| 556 | Brain Stem Neoplasms | 2.8% |
| 557 | Osteochondritis | 2.8% |
| 558 | Polymyalgia Rheumatica | 2.8% |
| 559 | Mycosis Fungoides | 2.8% |
| 560 | Lymphomatoid Papulosis | 2.8% |
| 561 | Plasmablastic lymphoma | 2.8% |
| 562 | Polycythemia Vera | 2.7% |
| 563 | Osteogenesis Imperfecta | 2.7% |
| 564 | Choroid Plexus Papilloma | 2.7% |
| 565 | Keloid | 2.7% |
| 566 | Noonan Syndrome | 2.5% |
| 567 | Hypopharyngeal Neoplasms | 2.5% |
| 568 | Pleural Effusion, Malignant | 2.5% |
| 569 | Hypopharyngeal Cancer | 2.5% |
| 570 | Waldenstrom Macroglobulinemia | 2.5% |
| 571 | Multiple Myeloma | 2.5% |
| 572 | Laryngeal neoplasm | 2.5% |
| 573 | Parotid Neoplasms | 2.5% |
| 574 | Prostatic Neoplasms, Castration-Resistant | 2.5% |
| 575 | Nelson Syndrome | 2.5% |
| 576 | Bladder Neoplasm | 2.4% |
| 577 | Kidney Neoplasm | 2.4% |
| 578 | Ureteral Neoplasms | 2.4% |
| 579 | Urethral Neoplasms | 2.4% |
| 580 | Tonsillar Neoplasms | 2.3% |
| 581 | Cerebellar Neoplasms | 2.3% |
| 582 | Rheumatoid Arthritis | 2.3% |
| 583 | Juvenile arthritis | 2.3% |
| 584 | Marfan Syndrome | 2.3% |
| 585 | Zollinger-Ellison syndrome | 2.2% |
| 586 | Lupus Nephritis | 2.2% |
| 587 | Homocystinuria | 2.2% |
| 588 | Cecal Neoplasms | 2.1% |
| 589 | Duodenal Neoplasms | 2.1% |
| 590 | Burkitt Lymphoma | 2.1% |
| 591 | Rheumatoid Nodule | 2% |
| 592 | Sezary Syndrome | 2% |
| 593 | Laryngomalacia | 2% |
| 594 | Appendiceal Neoplasms | 2% |
| 595 | Colonic Neoplasms | 2% |
| 596 | Rectal Neoplasms | 2% |
| 597 | Pectus carinatum | 2% |
| 598 | Nasopharyngeal Neoplasms | 1.9% |
| 599 | Colorectal Neoplasms | 1.8% |
| 600 | Paranasal Sinus Neoplasms | 1.7% |
| 601 | Felty Syndrome | 1.7% |
| 602 | Bronchomalacia | 1.7% |
| 603 | Tracheomalacia | 1.7% |
| 604 | Anus Neoplasms | 1.7% |
| 605 | Sigmoid Neoplasms | 1.7% |
| 606 | Maxillary Sinus Neoplasms | 1.5% |
| 607 | Rheumatoid Vasculitis | 1.4% |
| 608 | Mucopolysaccharidosis III | 1.4% |
| 609 | Sicca Syndrome | 1.2% |
| 610 | Sjogren's Syndrome | 1.2% |
| 611 | Lupus Vasculitis, Central Nervous System | 1% |
| 612 | Mucopolysaccharidosis II | 1% |
